115 related articles for article (PubMed ID: 1793727)
1. On the receiving end. IV: Validation of quality of life indicators.
Butow P; Coates A; Dunn S; Bernhard J; Hürny C
Ann Oncol; 1991 Sep; 2(8):597-603. PubMed ID: 1793727
[TBL] [Abstract][Full Text] [Related]
2. On the receiving end--III. Measurement of quality of life during cancer chemotherapy.
Coates A; Glasziou P; McNeil D
Ann Oncol; 1990; 1(3):213-7. PubMed ID: 2261367
[TBL] [Abstract][Full Text] [Related]
3. Responsiveness of a single-item indicator versus a multi-item scale: assessment of emotional well-being in an international adjuvant breast cancer trial.
Hürny C; Bernhard J; Coates A; Peterson HF; Castiglione-Gertsch M; Gelber RD; Rudenstam CM; Collins J; Lindtner J; Goldhirsch A; Senn HJ
Med Care; 1996 Mar; 34(3):234-48. PubMed ID: 8628043
[TBL] [Abstract][Full Text] [Related]
4. On the receiving end--II. Linear analogue self-assessment (LASA) in evaluation of aspects of the quality of life of cancer patients receiving therapy.
Coates A; Dillenbeck CF; McNeil DR; Kaye SB; Sims K; Fox RM; Woods RL; Milton GW; Solomon J; Tattersall MH
Eur J Cancer Clin Oncol; 1983 Nov; 19(11):1633-7. PubMed ID: 6315445
[TBL] [Abstract][Full Text] [Related]
5. Quality of life assessment in patients receiving adjuvant therapy for breast cancer: the IBCSG approach. The International Breast Cancer Study Group.
Bernhard J; Hürny C; Coates AS; Peterson HF; Castiglione-Gertsch M; Gelber RD; Goldhirsch A; Senn HJ; Rudenstam CM
Ann Oncol; 1997 Sep; 8(9):825-35. PubMed ID: 9358933
[TBL] [Abstract][Full Text] [Related]
6. "Fatigue and malaise" as a quality-of-life indicator in small-cell lung cancer patients. The Swiss Group for Clinical Cancer Research (SAKK).
Hürny C; Bernhard J; Joss R; Schatzmann E; Cavalli F; Brunner K; Alberto P; Senn HJ; Metzger U
Support Care Cancer; 1993 Nov; 1(6):316-20. PubMed ID: 8156249
[TBL] [Abstract][Full Text] [Related]
7. Cancer caregiver quality of life: need for targeted intervention.
Lapid MI; Atherton PJ; Kung S; Sloan JA; Shahi V; Clark MM; Rummans TA
Psychooncology; 2016 Dec; 25(12):1400-1407. PubMed ID: 26360934
[TBL] [Abstract][Full Text] [Related]
8. Quality of life measures for patients receiving adjuvant therapy for breast cancer: an international trial. The International Breast Cancer Study Group.
Hürny C; Bernhard J; Gelber RD; Coates A; Castiglione M; Isley M; Dreher D; Peterson H; Goldhirsch A; Senn HJ
Eur J Cancer; 1992; 28(1):118-24. PubMed ID: 1567662
[TBL] [Abstract][Full Text] [Related]
9. Quality of life is improved in breast cancer patients by Standardised Mistletoe Extract PS76A2 during chemotherapy and follow-up: a randomised, placebo-controlled, double-blind, multicentre clinical trial.
Semiglazov VF; Stepula VV; Dudov A; Schnitker J; Mengs U
Anticancer Res; 2006; 26(2B):1519-29. PubMed ID: 16619567
[TBL] [Abstract][Full Text] [Related]
10. Clinical relevance of single item quality of life indicators in cancer clinical trials.
Bernhard J; Sullivan M; Hürny C; Coates AS; Rudenstam CM
Br J Cancer; 2001 May; 84(9):1156-65. PubMed ID: 11336464
[TBL] [Abstract][Full Text] [Related]
11. Validation evidence for the French Canadian adaptation of the Multidimensional Fatigue Inventory as a measure of cancer-related fatigue.
Fillion L; Gélinas C; Simard S; Savard J; Gagnon P
Cancer Nurs; 2003 Apr; 26(2):143-54. PubMed ID: 12660563
[TBL] [Abstract][Full Text] [Related]
12. Assessing Emotional Functioning with Increased Power: Relative Validity of a Customized EORTC Short Form in the International ACTION Trial.
Jabbarian LJ; Groenvold M; Petersen MA; Christensen CA; Deliens L; van der Heide A; Kars MC; Miccinesi G; Payne S; Wilcock A; Korfage IJ;
Value Health; 2019 Jan; 22(1):92-98. PubMed ID: 30661639
[TBL] [Abstract][Full Text] [Related]
13. Assessment of the quality of life of patients with advanced cancer.
Gough IR; Furnival CM; Schilder L; Grove W
Eur J Cancer Clin Oncol; 1983 Aug; 19(8):1161-5. PubMed ID: 6684561
[TBL] [Abstract][Full Text] [Related]
14. Quality of life index for patients with cancer.
Padilla GV; Presant C; Grant MM; Metter G; Lipsett J; Heide F
Res Nurs Health; 1983 Sep; 6(3):117-26. PubMed ID: 6556698
[TBL] [Abstract][Full Text] [Related]
15. Initial validation of the Mini-Mental Adjustment to Cancer (Mini-MAC) scale: study of Portuguese end-of-life cancer patients.
Pereira FM; Santos CS
Eur J Oncol Nurs; 2014 Oct; 18(5):534-9. PubMed ID: 24882368
[TBL] [Abstract][Full Text] [Related]
16. Depression burden, self-help interventions, and side effect experience in women receiving treatment for breast cancer.
Badger TA; Braden CJ; Mishel MH
Oncol Nurs Forum; 2001 Apr; 28(3):567-74. PubMed ID: 11338763
[TBL] [Abstract][Full Text] [Related]
17. Side-effects burden, psychological adjustment, and life quality in women with breast cancer: pattern of association over time.
Longman AJ; Braden CJ; Mishel MH
Oncol Nurs Forum; 1999 Jun; 26(5):909-15. PubMed ID: 10382190
[TBL] [Abstract][Full Text] [Related]
18. Refinement and revalidation of the demoralization scale: The DS-II-external validity.
Robinson S; Kissane DW; Brooker J; Hempton C; Michael N; Fischer J; Franco M; Sulistio M; Clarke DM; Ozmen M; Burney S
Cancer; 2016 Jul; 122(14):2260-7. PubMed ID: 27171544
[TBL] [Abstract][Full Text] [Related]
19. All's well that ends well? Quality of life and physical symptom clusters in long-term cancer survivors across cancer types.
Zucca AC; Boyes AW; Linden W; Girgis A
J Pain Symptom Manage; 2012 Apr; 43(4):720-31. PubMed ID: 22277904
[TBL] [Abstract][Full Text] [Related]
20. Retrospective Evaluation of Clinical Experience With Intravenous Ascorbic Acid in Patients With Cancer.
Bazzan AJ; Zabrecky G; Wintering N; Newberg AB; Monti DA
Integr Cancer Ther; 2018 Sep; 17(3):912-920. PubMed ID: 29771164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
